Novartis oncology, over and out
English version
The team at Novartis Oncology in Argentina is waiting expectantly after learning that CEO Aliya Omer is moving on after barely a year in the country. Most of...
Podcast: the week in English
English version
A one-minute audio summary of pharma news in Argentina for the first week of November 2018.
The public medical provider PAMI and its agreement with drugmakers remains the...
Podcast: the week in English
English version
A one-minute audio summary of pharma news in Argentina for the last week of October 2018.
The main story in this edition: drugmakers' agreements...
L’oréal: Favre to Argentina
English version.
Frenchman Damien Favre had to abandon the glamorous Italian market to take on the devalued mass consumption market in Argentina. Favre is starting his tenure with price increases...
End of an era at Glaxo
English version
The tenure of the Argentine Rodolfo Civale at the helm of the UK’s GSK for the Southern Cone has come to an end....
Roemmers buys Sidus Paraguay
English version
The Roemmers group continues to expand its presence in the region. It's moved forward two steps in Paraguay with the purchase of the local branch...
Valsartan measures in Latam
English version
The international recall of valsartan is directly impacting the cardio segment in Latin America. After the EMA made the first move and the FDA also stepped in, Pharmabiz...
Layoffs at Glenmark Argentina
English version
The Argentine mendicines industry suffers setbacks as Indian drugmaker Glenmark cuts costs and lays off 20% of its manufacturing workforce in the country, Pharmabiz has learned.
Indian drugmaker Glenmark is making...
Mega Pharma buys Celsius
English version
Latin Pharma firms continue to make headlines. Now the Mega Pharma group has bought the Uruguayan drugmaker Celsius in a move that will give it control over 30%...
Masipack in crisis in Brazil
English version
Brazil's Grupo Masipack, which manufactures machinery for the pharma sector, is in financial crisis. The president of the company blames the problems on the recession in Brazil.
Brazil's Grupo...
Sartorius hosts Open Talks
English version
Germany's Sartorius is bringing its star speaker Stefan Schlack to Argentina. The executive is arriving in the country for Open Talks at Buenos Aires' MALBA museum.
Germany's Sartorius is looking to the region inviting...
New investors at Biosidus
English version
Argentine drugmaker Biosidus has opened the door to new shareholders: the investment funds Acon Investments and Humus Capital Partners, which will now control the company.
Pharmabiz has learned that Biosidus, which had...
Argentine pay talks close at 20%
English version
Collective pay negotiations in the Argentine pharma sector have closed reaching with an agreement of a 20% pay increase in three phases. The agreement...
Roemmers leaves Mega Pharma
English version
The Roemmers family has broken its ties with the Struengmann family, leaving Uruguay-based Latin pharma giant Mega Pharma, which was founded in 2002.
International drugmakers are continually restructuring and Latin America's...
BMS stikes deal with state producer.
English version
The patent on the antirretroviral Reyataz recently expired. The US firm BMS had been selling the product to the Argentine state for a decade as part of the...
Andrómaco: deal with Leo Pharma
English version
Argentine firm Andrómaco has closed a deal with Danish drugmaker Leo Pharma to bring Picato to Argentina The anti-actinic transparent gel will come under the firm's prescription medicines business.
Argentine firm Andrómaco has closed a...
Pharma review of the year 2017
English version
The "un-termination" of the agreement with PAMI, Argentina’s state funded health provision for pensioners, was possibly the key and most controversial topic of 2017....
Pharmabiz celebrates 10 years
English version
Pharmabiz, Latin America's top digital source of news on the pharmaceutical industry, is celebrating ten years. Its first decade of existence has seen it...
Argentina’s reign of fragrance imitations
English version
It’s not unusual to come across imitations of luxury fragrances, but companies have taken it as far as Argentine direct sales company Reino....
Baxter divests in Argentina
English version:
US firm Baxter is divesting in Argentina. Led by regional head Marcelo Rozas, the multinational is in the due diligence process to sell its clinic Daomi for...
Abbott: confusion over new device
English version:
Abbott launched a misleading campaign green-lighted by Argentine CEO for the diabetes division, Nicolás Mendiberri, and José María Oribe's press agency, that seemed to falsely...
Pfizer opens new plant
English version
US drugmaker Pfizer has opened a new soft capsule production plant in the Buenos Aires neighborhood of Villa Soldati. The company has invested...
Exclusive: Argentina’s Sielecki buys back Phoenix from GSK
English version
Daniel Sielecki has bought back the drugmaker Phoenix. The company will come under the wings of Elea from December, following seven years of British ownership.
The...
Exclusive: Roemmers buys Elisium
English Version
Argentina’s Roemmers group has acquired local drugmaker Elisium. Sources have told Pharmabiz that the group will pay close to US$ 20 million to buy the...
Sanofi Argentina ousts CEO
English Version
French drugmaker Sanofi has said goodbye to its Argentina CEO Sergio Navarro Hufenbach. In a calculated chess move, the Swiss Sebastien Delarive has...
Fresenius opens Argentine plant
English Version
German group Fresenius has opened its new manufacturing plant on the Ezeiza industrial park. The site will focus on producing parenteral solutions.
German healthcare group Fresenius has launched a new manufacturing plant...
Mega Pharma plans stock market launch?
English Version
Uruguayan drugmaker Mega Pharma is said to be planning to make an initial public offering either in the US or somewhere in Latin America.
Uruguayan...
Puig bets on trips for editors
English Version
Drugmarkers’ invitations to science journalists are almost nonexistent these days. Compliance rules, mainly among multinationals, have succeeded in almost burying that practice, but it appears...
IMS: Emerging markets, prices and perspectives
The IMS World Review 2014 took place today in Buenos Aires, at Puerto Salguero, in Costa Salguero exhibition center.
English version
The IMS World Review 2014...
Novartis: new local head of oncology
English version
Gustavo Gil has retired from Swiss drugmaker Novartis. He led the oncology division in Argentina for more than a decade. The American Aliya Omer takes his place.
May...
KPMG gets its data in a twist in Argentina
English version
International consultation and auditing company KPMG is getting its data in a twist in Argentina, at least in the Pharma sector.
International consultation and auditing company KPMG,...
Pharmabiz launches You Tube reports
English Version
Pharmabiz, the leading specialist on the Latin American pharmaceutical and cosmetics industries, is expanding its journalistic output to include You Tube video reports.
The two-minute...
Argentine drugmakers buy bunch of Abbott brands
English Version
The deals and acquisitions in the pharma industry continue even as the bells are about to ring for New Year.
The deals and acquisitions...
New player in the Pharma adhesives market
English Version
Facundo Schiavone (ex Andreani) and Jorge Muixi (ex H.B. Fuller) have launched a new company in the Argentine market.
Facundo Schiavone (ex Andreani) and Jorge Muixi (ex H.B. Fuller) have launched a...
Marken (soon to be UPS) cuts the ribbon at new facilities...
English Version
Pharmabiz was present as the clinical trials logistics company Marken cut the ribbons on a new operations centre yesterday.
Pharmabiz was present as the...
Dufour returns in the hands of home cleaning products
English Version
Argentine men's deodorant and fragrance brand Dufour is returning in the hands of the owners of a classic home cleaning product.
Argentine men's deodorant and...
Argentine pharma companies looking abroad
English Version
Argentine firms feeling the pinch from an ongoing recession at home are looking abroad for expansion.
Argentine firms feeling the pinch from an ongoing...
Traceability: new rules
English Version
As predicted by Pharmabiz, Argentina's regulator ANMAT has introduced new rules for drugs traceability.
Ruling number 10564, published in Argentina's governmental bulletin, merges previous lists of...
Richmond continues regional expansion with new company in Uruguay
English Version
Argentine drugmaker Richmond, led by Marcelo Figueiras, has informed the country's national securities commission that is has decided to register a limited company in...
Droguería del Sud opens new facilities
English Version
Argentine president Mauricio Macri cut the ribbon at Droguería del Sud's new central distribution centre in the province of Buenos Aires.
Argentine president Mauricio Macri cut the...
Indian drugmakers focus on Latin America
English Version
India’s phamaceutical industry continues to look for strategic allies in Latin America and seems to have its eyes on Peru.
India’s phamaceutical industry continues to look...
Colorcon: new CEO and projects
Colorcon has a new regional CEO. Now at the helm in South America is Rafael Falco, who was previously the company’s sales manager for the southern cone.
English...
Layoffs at AstraZeneca
Anglo-Swedish drugmaker AstraZeneca is laying off 100 employees in Argentina. Under new CEO Gustavo Mizraje, the local operation is making the cuts in the areas of administration...
More layoffs at Biogen
English Version
Global biotech firm Biogen continues to lay off staff in Argentina while rumours circulate that it might leave the country altogether.
Global biotech firm Biogen continues...
Bayer event: focus on Latin America
English Version
Bayer brought together a legion of Latin American journalists for a press conference in Buenos Aires to outline its plans for the continent and...
Danish drugmaker lays off local director
Alberto Weder’s 15-year tenure at the helm of Danish drugmaker Lundbeck’s Argentine concern has been brought to an end.
English version
Alberto Weder’s 15-year tenure at...
Argentine biotech firm in crisis: debts and layoffs
Sources say the company is considering opening crisis prevention talks with Argentina’s Ministry of Work, but official spokesmen have denied this.
English Version
Argentine biotech firm Amega Biotech is facing financial...
AstraZeneca signs licensing deal
Swiss/British drugmaker AstraZeneca has closed a new licensing agreement with Argentine firm GP Pharm, Pharmabiz can exclusively reveal.
English Version
Swiss/British drugmaker AstraZeneca has closed a new licensing agreement with Argentine...
German drugmaker Stada buys Argentine generics producer
The post-Davos influx of foreign investment appears to be arriving more quickly than expected, starting with German drugmaker Stada's purchase of Argentine generics producer Vannier.
English Version
The...
Argentina signs Hepatitis C agreement
The Argentine health ministry today signed a u$s 5.4 million contract for the direct purchase of Hepatitis C treatments Sovaldi and Probirase.
English Version
The Argentine health ministry...
Argentine firm buys German plant
Argentine businessman Jorge Braver has bought an oncology plant from German firm Fresenius Kabi's – specialists in infusion therapy and parenteral nutrition.
English Version
Argentine businessman Jorge Braver has bought an...
Eurofarma buys Sanofi Argentine plant
English Version
Brazilian firm Eurofarma has bought Sanofi’s plant in Lomas del Mirador, Argentina. The decision comes after a long process of due diligence in which the company, overseen by Mauricio...
Unilever sells Argentine brands and plant
The operation still needs the OK from the Argentine secretary of commerce but is expected to get the go-ahead.
English Version
Unilever sells Argentine brands and plant British-Dutch...
Farré with the stars
English Version
Fernando Farré loved being close to celebrities, and his position at Coty granted him access thanks to the company’s wide portfolio of fragrances associated with different stars.
Fernando...
Ex-Coty director arrested for wife’s murder
Although Farré left the company almost a year ago, the murder will without doubt have an impact on Coty’s image.
English Version
Fernando Farré, the former general...
GSK’s malaria vaccine still a long way from roll-out in Africa
English Version
Many media sources, including Argentina’s Clarín newspaper, reported in July that the vaccine had “been approved”, when in fact it had only received...
Health minister in India
Argentine health minister Daniel Gollan is in India attempting to establish agreements with generics manufacturers, Pharmabiz has learned from reliable sources.
English Version
Argentine health minister...
Murray: global pharma perspectives
New Zealander Murray Aitken, Executive Director of IMS Institute for Healthcare Informatics, arrived in Argentina to give his global perspectives.
English Version
New Zealander Murray Aitken –Executive Director of IMS...
Novartis sells local brand in Argentina
Swiss pharmaceutical company Novartis has sold its leading local anti-nausea brand Reliverán to Argentine firm Gador.
English version
Swiss pharmaceutical company Novartis has sold its leading...
Layoffs and restructuring at GSK
English Version
Pharma multinational GSK this week sat at the table at the Argentine Ministry of Work opposite the trade union for pharmaceutical sales representatives....
HLB buys AstraZeneca Rontag line
English Version
Argentine firm HLB Pharma led by Hernán López Bernabó has acquired the Rontag line from British-Swedish multinational AstraZeneca for close to ten million...
Nestlé signs deal with Cassará
Swiss multinational Nestlé has closed a deal with Argentine pharma company Cassará to expand its presence in the local market.
English Version
Swiss multinational Nestlé has closed a deal with Argentine pharma...
Phytomedicine approval in Uruguay
English Version
Uruguayan firm Botica del Señor has launched a medicine derived from chamerion angustifolium to be used for the treatment of benign prostatic hyperplasia.
Uruguayan firm Botica del Señor has...
Sidus reduces staff by 30%
Argentine pharmaceutical group Sidus has completed a round of voluntary redundancies covering all areas of the company. The deadline for take-up was Friday October 31.
English Version
Argentine pharmaceutical group Sidus has...
Savant opens new plant
The Argentine pharmaceutical company Savant has cut the ribbon at a new softgel capsule plant in the town of El Tío, Córdoba.
English version
In Córdoba–...
Abbott acquires Recalcine
US pharma company Abbott has completed its acquisition of Chilean firm CFR Recalcine, doubling its presence in the Latin American generics market.
English version
US pharma company Abbott has completed its acquisition...
Roemmers signs license for Menarini line
Argentina's Roemmers group has signed an agreement to take on most of the products belonging to Italian pharmaceutical firm Menarini, which abandoned Argentina in...
Ferring sold Dupomar to Investi
The Swedish laboratory Ferring has sold the Dupomar line, which they had acquired ten years before, to the national company Investi.
English version
The Swedish laboratory Ferring has sold the Dupomar line, which they...
Argentine government adds three vaccines
Argentine president Cristina Fernández de Kirchner has announced the addition of three new vaccines to the country's official immunisation schedule at a cost of $82...
Bagó forms new company
Argentine company Bagó has entered a joint venture with Dutch firm Synthon. The new enterprise, Synthon Bagó, is to specialise in multiple sclerosis.
English version
Argentine...
GSK & Elea sell non-core products
The Argentinean laboratory Elea and the British company Phoenix –which is part of the firm GlaxoSmithKline – have sold many of their non-core products...
Menarini to cease operations in Argentina
The Italian laboratory Menarini has decided to close its operations in Argentina. The decision was announced yesterday at the Ministry of Labor after a meeting on previously announced...
GSK came out swinging
The British Company GSK has touched several sore spots in its latest annual report with strong statements about intellectual property, pricing controls, and emerging...
Valeant – on a nosedive due to devaluation?
Pharmaceutical company B+L, now renamed Valeant, is downsizing on a major scale in Argentina.The first step came back in September when the company cut ties...
Congress: prices, industry and more
Argentine president Cristina Fernández de Kirchner opened the 132nd assembly of the National Congress in Buenos Aires on Saturday, marking the start of the 2014 legislative sessions.
English...
Savant: Corporate Bonds with Bancor, James, and Others
The national laboratory Savant revamped its name. The company that was founded by Mauro Bono now changed its name to “Savant” in a strategic reduction associated with simplicity.
English...
Dromex: new softgel plant
Julio Scardigli's Dromex Group has cut the ribbon on a new soft capsule plant at the recently-opened Ezeiza industrial estate in the province of...
Hané and Hernán Bernabó, allies
The noted Jorge Hané and the no less renowned pharmaceutical businessman Hernán López Bernabó signed an agreement between companies.
English version
The noted Jorge Hané and...
Capano, end to a stage in B.I
After 21 years in the company, Fabio Capano leaves the German Boehringer Ingelheim as of January 2014.
English version
Fabio Capano leaves the German Boehringer Ingelheim...
Pfizer – Another Woman at the Forefront
The American Pfizer has appointed Adriana Belardinelli as site manager of its manufacturing plant in Argentina.
English version
The American Pfizer has appointed Adriana Belardinelli...
Roemmers Launches Nutraceutical
Roemmers group launched a line of instant formulas named Nutri Baby through its laboratory Argentia.
English version
Roemmers group launched a line of instant formulas named Nutri...
MSD: Dismissals Are Coming
The American company Merck announced a global initiative aiming to focus on R&D as well as cutting back on trade costs.
English version
The American company Merck announced a global...
Milk: No More Nestlé?
Baby formula market is changing by leaps and bounds in the region. It is a constantly growing business on which mega companies have had...
GSK in the limelight over bribery allegations
Pharmaceutical company GSK is on tenterhooks after the Chinese government accused it of being behind a massive corruption scandal.
English version
Pharmaceutical company GSK is on...
Cassará in 50-50 partnership with APOTEX
The national firm Laboratorios Cassará reached an agreement with the Canadian company Apotex in order to participate in its local operation.
English version
The national firm Laboratorios Cassará...
Roemmers Opens Dermo-cosmetic Division
Roemmers Group continues to create new business units and to forge projects. This time, it gave shape to its division baptized Belleza y Salud -Beauty...
LiquidCap: new capsules with liquid
The national laboratory Novocap is tying its boots to go out into the field with a cutting-edge and differentiated technology in the local market....
IMS World Review: emerging countries, prices and more
The IMS World Review 2013 took place today at the Buenos Aires Auditorium in the Recoleta neighbourhood. The event had a special flavour this year because...
Maprimed, renegotiation and capital contribution
The leading producer of active pharmaceutical ingredients (APIs) in Argentina had adverse results in the 2012 business year that continued during the first quarter...
Valeant acquires Bausch + Lomb
The Canadian pharmaceutical company Valeant, agreed to acquire the laboratory specialized in ophthalmology Bausch & Lomb, owned by the Warburg Pincus fund.
English version
The Canadian pharmaceutical company Valeant, which...
Genomma bought Piecidex
English Version
The mexican laboratorio Genomma is looking for new brands to reinforce its growth in the dermocosmetics and over the counter medicine business. Therefore,...
Brazilian Cristália acquired the Argentine IMA
The Cristália group acquired the Argentine pharmaceutical company specialized in oncology, IMA Laboratorios. For over u$s10 million. In this way, the Zaffaroni family and...
